⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZURA News
Zura Bio Limited Class A Ordinary Shares
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
ZURA
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program
businesswire.com
ZURA
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
ZURA
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
businesswire.com
ZURA
Form 8-K
sec.gov
ZURA